查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2088628

神經血管導管市場：2026-2032年全球市場預測（依產品類型、材質、塗層類型、應用、最終用戶和分銷管道分類）

Neurovascular Catheters Market by Product Type, Material, Coating Type, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，神經血管導管市場規模將達到 124.5 億美元，複合年成長率為 12.64%。

主要市場統計數據
基準年 2025 54億美元
預計年份：2026年 59.7億美元
預測年份 2032 124.5億美元
複合年成長率 (%) 12.64%

神經血管導管插入執行摘要

神經血管導管是治療缺血性中風血栓切除術、動脈瘤栓塞術、輔助血流旁路移植術、抽吸術、血管通路建立以及診斷性腦血管血管造影術等必不可少的醫療設備。其需求源自於已證實的疾病負擔。世界衛生組織（WHO）將卒中列為全球主要死因和殘疾原因之一。根據美國疾病管制與預防中心（CDC）統計，美國每年發生超過79.5萬例中風，其中缺血性中風約佔87%。

神經血管導管插入術領域的變革性變化

神經血管導管的應用領域正從單純的介入器材發展成為時間敏感型中風治療系統中的綜合工具。美國心臟協會/美國卒中協會（AHA/ASA）指南建議，對於某些大血管閉塞，在滿足高級影像學標準的情況下，可在最後一次正常狀態後24小時內進行機械取栓術，從而將治療途徑擴展到早期療育之外。

人工智慧（AI）的累積影響

人工智慧 (AI) 透過改善患者識別、手術規劃和操作效率，對整個神經血管導管介入價值鏈產生累積影響。 FDA已通過核准的用於 CT 和 CTA 的 AI 分診工具能夠快速檢測和通知疑似大血管閉塞病例，並在工作流程有效整合的情況下，幫助卒中團隊減少「轉運至通知」和「轉運至穿刺」的延誤。

關鍵區域洞察

亞太地區人口眾多、人口老化嚴重、高血壓及糖尿病盛行率高、部分國家吸菸現象普遍，以及先進中風中心資源分配不均等，導致該地區中風負擔沉重。在日本、韓國、澳洲和中國的主要城市，由於三級醫療機構、專科培訓和先進診斷影像技術的發展，血管內治療的普及取得了顯著進展。同時，印度和東協市場正透過投資公立和私立醫院、進行中風宣傳教育以及逐步發展介入神經放射學能力而不斷擴大。

關鍵群體特定見解

東協地區的需求受多種因素影響，包括嚴重的卒中負擔、快速的都市化、非傳染性疾病患病率的上升以及成員國之間卒中治療基礎設施的差異，這些因素共同促成了醫療設備的引進和轉診網路建設，並促進了相關培訓。在海灣合作理事會（GCC）國家，透過對高階醫院的投資、集中採購、卒中治療服務的現代化以及政府主導的醫療改革項目，醫療器材的普及應用正在加速。在歐盟，先進的臨床技術和更嚴格的醫療設備法規（MDR）合規要求，使得擁有完善的技術文件、上市後臨床隨訪和真實世界性能證據的神經血管導管產品線更受青睞。

主要國家的概況

美國在神經血管導管介入術的應用方面主導，這得益於其高密度的卒中中心、獲得FDA批准的創新技術、成熟的取栓流程以及急救醫療服務與綜合卒中中心之間的緊密合作。在加拿大，重點在於各省醫療保健系統內循證的醫療服務可近性，而當地的轉診途徑和專科醫生的可及性則影響著該技術的普及。同時，墨西哥和巴西正在擴展其專業的介入神經放射學系統，尤其是在影像、重症監護和技術嫻熟的醫務人員集中的都市區醫院。

為行業領導者提供的實用建議

產業領導者應優先進行證據收集工作，以證實導管性能與手術效率、首次成功率、再灌注成功率、併發症減少、器械更換減少以及整體醫療價值之間的關聯。臨床教育應著重於器械選擇、遠端入路策略、抽吸技術、橈動脈和股動脈入路的比較、影像學結果的解讀以及併發症的處理，無論是在大型卒中中心還是新興卒中中心。

調查方法

本執行摘要基於對經核實的公共和機構來源的二手研究，包括世界衛生組織和美國疾病控制與預防中心的中風數據、美國心臟協會/美國卒中協會的臨床指南、美國食品藥品監督管理局的醫療設備資料庫、歐盟醫療器械法規的監管指南、同行檢驗的介入神經放射學中心標準文獻、醫院中風中心標準文獻、醫院中風出版物和公共衛生機構資訊來源。

結論

神經血管導管市場持續成長，這主要得益於中風治療系統的擴展、血栓切除術標準的明確，以及醫院對能夠提高手術速度、遠端通路、抽吸性能和手術可靠性的器械需求不斷增加。檢驗的流行病學數據和臨床指南也支持臨床上對抽吸導管、微導管、引導管、球囊引導管和遠端通路系統的持續需求。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 神經血管導管市場：依產品類型分類

  • 微導管
  • 球囊導管
  • 導管接入
  • 栓塞導管

第8章 神經血管導管市場：依材質

  • 聚醚嵌段醯胺
  • 聚乙烯
  • 聚氨酯
  • 氟化乙烯丙烯
  • 尼龍

第9章：神經血管導管市場：依塗層類型分類

  • 塗層導管
    • 親水塗層
    • 疏水塗層
  • 無塗層導管

第10章 神經血管導管市場：依應用領域分類

  • 腦動脈瘤
    • 囊狀動脈瘤
    • 梭形動脈瘤
  • 缺血性中風
    • 栓塞性中風
    • 血栓性中風
  • 動靜脈畸形
  • 硬腦膜動靜脈瘻管
  • 顱內動脈硬化

第11章 神經血管導管市場：依最終用戶分類

  • 門診手術中心
  • 醫院
    • 公立醫院
    • 私立醫院
  • 專科診所
  • 診斷影像中心
  • 研究機構

第12章 神經血管導管市場：依通路分類

  • 線上
  • 離線

第13章：神經血管導管市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章 神經血管導管市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 神經血管導管市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • Abbott Laboratories
  • Acandis GmbH
  • Asahi Intecc Co., Ltd.
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cook Medical LLC
  • ICU Medical, Inc.
  • Imperative Care Inc.
  • Inari Medical, Inc.
  • Integer Holdings Corporation
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson Services, Inc.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • Penumbra, Inc.
  • Phenox GmbH
  • Rapid Medical Ltd.
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation
  • Zeus Industrial Products, Inc.
Product Code: MRR-A339DAEF9DC3

The Neurovascular Catheters Market is projected to grow by USD 12.45 billion at a CAGR of 12.64% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 5.40 billion
Estimated Year [2026] USD 5.97 billion
Forecast Year [2032] USD 12.45 billion
CAGR (%) 12.64%

Neurovascular Catheters Executive Summary

Neurovascular catheters are essential devices for ischemic stroke thrombectomy, aneurysm coiling, flow-diversion support, aspiration, vascular access, and diagnostic cerebral angiography. Demand is anchored in verified disease burden: the World Health Organization identifies stroke as a leading global cause of death and disability, while the U.S. Centers for Disease Control and Prevention reports more than 795,000 strokes annually in the United States, with ischemic strokes representing about 87% of cases.

Market momentum is tied to faster stroke recognition, expansion of comprehensive stroke centers, and evidence-based endovascular care. Product differentiation increasingly centers on trackability, torque response, lumen size, aspiration efficiency, distal access stability, radiopacity, kink resistance, and compatibility with stent retrievers, embolic coils, balloons, guidewires, and adjunctive neurovascular devices.

Transformative Shifts in the Neurovascular Catheter Landscape

The neurovascular catheter landscape is shifting from procedure-enabling devices to integrated tools within time-critical stroke systems. AHA/ASA guidelines support mechanical thrombectomy for selected large vessel occlusion patients up to 24 hours from last known well when advanced imaging criteria are met, expanding the treatment pathway beyond early-window intervention.

Hospitals are prioritizing catheter platforms that shorten device exchanges, improve distal navigation, maintain stable support in tortuous anatomy, and support radial as well as femoral access. At the same time, EU MDR scrutiny, FDA quality expectations, and hospital value analysis committees are raising the bar for clinical evidence, post-market surveillance, biocompatibility documentation, human factors, and supply resilience.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is having a cumulative impact across the neurovascular catheter value chain by improving patient identification, procedural planning, and operational throughput. FDA-cleared AI triage tools for CT and CTA support rapid detection and notification of suspected large vessel occlusion, helping stroke teams reduce door-to-notification and door-to-puncture delays where workflow integration is effective.

AI is also influencing R&D through computational modeling, image-based anatomy mapping, virtual simulation, manufacturing quality analytics, and predictive maintenance of production systems. While catheter navigation remains physician-controlled, AI-enabled imaging, workflow orchestration, case prioritization, and predictive inventory planning are strengthening adoption of advanced neurovascular access, aspiration, and microcatheter systems.

Key Regional Insights

Asia-Pacific carries a substantial stroke burden because of population scale, aging, hypertension prevalence, diabetes, smoking exposure in several countries, and uneven access to advanced stroke centers. Japan, South Korea, Australia, and major Chinese cities show strong adoption of endovascular therapy supported by tertiary hospitals, specialist training, and advanced imaging availability, while India and ASEAN markets are expanding through public and private hospital investment, stroke awareness programs, and gradual development of neurointerventional capacity.

North America remains evidence-driven, supported by FDA-cleared technologies, established reimbursement pathways, clinical guideline adherence, and dense comprehensive stroke center networks in metropolitan areas. Europe benefits from established neurointerventional expertise, national stroke strategies, and cross-border clinical research activity, but faces EU MDR transition costs and documentation intensity that can affect product availability and adoption timing. Latin America, led by Brazil and Mexico, is expanding from a smaller base as urban hospitals add thrombectomy capabilities, although affordability, uneven reimbursement, and specialist concentration remain key barriers. The Middle East, particularly GCC states, is investing in specialist hospitals, advanced imaging, and medical tourism-linked tertiary care, while Africa remains constrained by limited CT/CTA availability, trained neurointerventional specialists, referral infrastructure, and catheter affordability, creating demand for training, access partnerships, and durable supply models.

Key Group Insights

ASEAN demand is shaped by a large stroke burden, rapid urbanization, rising noncommunicable disease prevalence, and variable stroke infrastructure across member countries, creating opportunities for training-linked device adoption and referral-network development. The GCC is accelerating uptake through premium hospital investment, centralized procurement, stroke service modernization, and government-led healthcare transformation programs. The European Union combines high clinical sophistication with stricter MDR compliance requirements, favoring neurovascular catheter portfolios supported by robust technical files, post-market clinical follow-up, and real-world performance evidence.

BRICS markets represent high-volume clinical need, especially in China, India, and Brazil, but require localization, pricing discipline, physician education, and regulatory navigation aligned with domestic device policies. G7 countries lead in clinical trials, reimbursement maturity, quality-system enforcement, and early adoption of advanced catheter technologies, including large-bore aspiration systems, distal access catheters, and next-generation microcatheters. NATO markets add emphasis on supply security, domestic or allied manufacturing capacity, cyber-resilient hospital infrastructure, and continuity of critical medical device access during geopolitical or logistics disruptions.

Key Country Insights

The United States leads in neurovascular catheter adoption due to stroke center density, FDA-cleared innovation, mature thrombectomy workflows, and strong integration of emergency medical services with comprehensive stroke centers. Canada emphasizes evidence-based access across provincial systems, with adoption influenced by regional referral pathways and specialist availability, while Mexico and Brazil are expanding specialized neurointerventional capacity, especially in major urban hospitals where imaging, intensive care, and trained operators are concentrated.

In Europe, the United Kingdom, Germany, France, Italy, and Spain benefit from mature stroke networks, national or regional thrombectomy pathways, and established neurointerventional training, although procurement rules, hospital budget pressure, and MDR compliance affect adoption timing. Russia maintains demand in large tertiary centers with neurovascular expertise, but access outside major cities remains less uniform. In Asia-Pacific, China and India offer scale driven by high stroke burden and expanding tertiary care, Japan and South Korea emphasize high-precision neurointervention, advanced imaging, and physician specialization, and Australia supports guideline-based stroke care through advanced metropolitan networks, telestroke coordination, and regional retrieval systems.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize evidence generation that links catheter performance to procedural efficiency, first-pass effect, reperfusion success, complication reduction, reduced device exchanges, and total episode-of-care value. Clinical education should focus on device selection, distal access strategy, aspiration technique, radial versus femoral access considerations, imaging interpretation, and complication management across both high-volume and emerging stroke centers.

Commercial teams should pair premium innovation with tiered portfolios for cost-sensitive markets while maintaining consistent quality, traceability, and regulatory documentation. Manufacturers should strengthen dual sourcing, regulatory readiness, AI-enabled quality systems, sterile packaging validation, and physician feedback loops. Partnerships with imaging AI developers, stroke networks, emergency care programs, and training societies can improve adoption while supporting measurable improvements in time-to-treatment and procedural consistency.

Research Methodology

This executive summary is based on secondary research from verified public and institutional sources, including WHO and CDC stroke data, AHA/ASA clinical guidelines, FDA device databases, EU MDR regulatory guidance, peer-reviewed neurointerventional literature, hospital stroke center standards, clinical trial publications, and public health agency resources.

The methodology triangulates disease burden, guideline eligibility, regulatory trends, hospital purchasing behavior, neurointerventional workflow requirements, and technology adoption indicators. Insights were validated through cross-source comparison and excluded unsupported market-size, market-share, and forecast claims, ensuring that conclusions remain data-backed, clinically grounded, and relevant for neurovascular catheter market analysis.

Conclusion

The neurovascular catheters market is advancing as stroke systems expand, thrombectomy eligibility becomes more operationalized, and hospitals demand devices that improve speed, distal access, aspiration performance, and procedural confidence. Verified epidemiology and clinical guidelines support sustained clinical need for aspiration catheters, microcatheters, guide catheters, balloon guide catheters, and distal access systems.

Future competitiveness will depend on clinical evidence, regulatory execution, AI-enabled workflow integration, operator training, and the ability to serve both advanced and resource-constrained markets. Organizations that combine innovation with affordability, supply resilience, quality assurance, and measurable clinical support are best positioned for durable growth in neurovascular intervention.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Neurovascular Catheters Market, by Product Type

  • 7.1. Microcatheters
  • 7.2. Balloon Catheters
  • 7.3. Access Catheters
  • 7.4. Embolization Catheters

8. Neurovascular Catheters Market, by Material

  • 8.1. Polyether Block Amide
  • 8.2. Polyethylene
  • 8.3. Polyurethane
  • 8.4. Fluorinated Ethylene Propylene
  • 8.5. Nylon

9. Neurovascular Catheters Market, by Coating Type

  • 9.1. Coated Catheters
    • 9.1.1. Hydrophilic Coating
    • 9.1.2. Hydrophobic Coating
  • 9.2. Uncoated Catheters

10. Neurovascular Catheters Market, by Application

  • 10.1. Brain Aneurysm
    • 10.1.1. Saccular Aneurysm
    • 10.1.2. Fusiform Aneurysm
  • 10.2. Ischemic Stroke
    • 10.2.1. Embolic Stroke
    • 10.2.2. Thrombotic Stroke
  • 10.3. Arteriovenous Malformations
  • 10.4. Dural Arteriovenous Fistulas
  • 10.5. Intracranial Atherosclerosis

11. Neurovascular Catheters Market, by End User

  • 11.1. Ambulatory Surgery Centers
  • 11.2. Hospitals
    • 11.2.1. Public Hospitals
    • 11.2.2. Private Hospitals
  • 11.3. Specialty Clinics
  • 11.4. Diagnostic Imaging Centers
  • 11.5. Research Institutes

12. Neurovascular Catheters Market, by Distribution Channel

  • 12.1. Online
  • 12.2. Offline

13. Neurovascular Catheters Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. North America
  • 13.3. Latin America
  • 13.4. Europe
  • 13.5. Middle East
  • 13.6. Africa

14. Neurovascular Catheters Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Neurovascular Catheters Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. Abbott Laboratories
  • 17.2. Acandis GmbH
  • 17.3. Asahi Intecc Co., Ltd.
  • 17.4. B. Braun Melsungen AG
  • 17.5. Becton, Dickinson and Company
  • 17.6. Boston Scientific Corporation
  • 17.7. Cook Medical LLC
  • 17.8. ICU Medical, Inc.
  • 17.9. Imperative Care Inc.
  • 17.10. Inari Medical, Inc.
  • 17.11. Integer Holdings Corporation
  • 17.12. Integra LifeSciences Holdings Corporation
  • 17.13. Johnson & Johnson Services, Inc.
  • 17.14. Medtronic plc
  • 17.15. Merit Medical Systems, Inc.
  • 17.16. MicroPort Scientific Corporation
  • 17.17. Penumbra, Inc.
  • 17.18. Phenox GmbH
  • 17.19. Rapid Medical Ltd.
  • 17.20. Stryker Corporation
  • 17.21. Teleflex Incorporated
  • 17.22. Terumo Corporation
  • 17.23. Zeus Industrial Products, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL NEUROVASCULAR CATHETERS MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL NEUROVASCULAR CATHETERS MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL NEUROVASCULAR CATHETERS MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL NEUROVASCULAR CATHETERS MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL NEUROVASCULAR CATHETERS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL NEUROVASCULAR CATHETERS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY COATING TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY COATING TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MICROCATHETERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MICROCATHETERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MICROCATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BALLOON CATHETERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BALLOON CATHETERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BALLOON CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ACCESS CATHETERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ACCESS CATHETERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ACCESS CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL EMBOLIZATION CATHETERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL EMBOLIZATION CATHETERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL EMBOLIZATION CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL POLYETHER BLOCK AMIDE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL POLYETHER BLOCK AMIDE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL POLYETHER BLOCK AMIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL POLYETHYLENE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL POLYETHYLENE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL POLYETHYLENE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL POLYURETHANE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL POLYURETHANE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL POLYURETHANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL FLUORINATED ETHYLENE PROPYLENE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL FLUORINATED ETHYLENE PROPYLENE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL FLUORINATED ETHYLENE PROPYLENE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL NYLON MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL NYLON MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL NYLON MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL COATED CATHETERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL COATED CATHETERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL COATED CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL HYDROPHILIC COATING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL HYDROPHILIC COATING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL HYDROPHILIC COATING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL HYDROPHOBIC COATING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL HYDROPHOBIC COATING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL HYDROPHOBIC COATING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL UNCOATED CATHETERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL UNCOATED CATHETERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL UNCOATED CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BRAIN ANEURYSM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BRAIN ANEURYSM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BRAIN ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SACCULAR ANEURYSM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SACCULAR ANEURYSM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SACCULAR ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL FUSIFORM ANEURYSM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL FUSIFORM ANEURYSM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL FUSIFORM ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ISCHEMIC STROKE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ISCHEMIC STROKE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ISCHEMIC STROKE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL EMBOLIC STROKE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL EMBOLIC STROKE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL EMBOLIC STROKE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL THROMBOTIC STROKE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL THROMBOTIC STROKE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL THROMBOTIC STROKE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ARTERIOVENOUS MALFORMATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ARTERIOVENOUS MALFORMATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ARTERIOVENOUS MALFORMATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL DURAL ARTERIOVENOUS FISTULAS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL DURAL ARTERIOVENOUS FISTULAS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL DURAL ARTERIOVENOUS FISTULAS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL INTRACRANIAL ATHEROSCLEROSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL INTRACRANIAL ATHEROSCLEROSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL INTRACRANIAL ATHEROSCLEROSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL DIAGNOSTIC IMAGING CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL DIAGNOSTIC IMAGING CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL DIAGNOSTIC IMAGING CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ONLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC NEUROVASCULAR CATHETERS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC NEUROVASCULAR CATHETERS MARKET SIZE, BY COATED CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC NEUROVASCULAR CATHETERS MARKET SIZE, BY BRAIN ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC NEUROVASCULAR CATHETERS MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC NEUROVASCULAR CATHETERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY COATED CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY BRAIN ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY COATED CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY BRAIN ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY COATED CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY BRAIN ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST NEUROVASCULAR CATHETERS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST NEUROVASCULAR CATHETERS MARKET SIZE, BY COATED CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST NEUROVASCULAR CATHETERS MARKET SIZE, BY BRAIN ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST NEUROVASCULAR CATHETERS MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST NEUROVASCULAR CATHETERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY COATED CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY BRAIN ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN NEUROVASCULAR CATHETERS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN NEUROVASCULAR CATHETERS MARKET SIZE, BY COATED CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN NEUROVASCULAR CATHETERS MARKET SIZE, BY BRAIN ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN NEUROVASCULAR CATHETERS MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 179. ASEAN NEUROVASCULAR CATHETERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 180. GCC NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 181. GCC NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. GCC NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 183. GCC NEUROVASCULAR CATHETERS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. GCC NEUROVASCULAR CATHETERS MARKET SIZE, BY COATED CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 185. GCC NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. GCC NEUROVASCULAR CATHETERS MARKET SIZE, BY BRAIN ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 187. GCC NEUROVASCULAR CATHETERS MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
  • TABLE 188. GCC NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. GCC NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 190. GCC NEUROVASCULAR CATHETERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPEAN UNION NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION NEUROVASCULAR CATHETERS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION NEUROVASCULAR CATHETERS MARKET SIZE, BY COATED CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION NEUROVASCULAR CATHETERS MARKET SIZE, BY BRAIN ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPEAN UNION NEUROVASCULAR CATHETERS MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPEAN UNION NEUROVASCULAR CATHETERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 202. BRICS NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 203. BRICS NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS NEUROVASCULAR CATHETERS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS NEUROVASCULAR CATHETERS MARKET SIZE, BY COATED CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS NEUROVASCULAR CATHETERS MARKET SIZE, BY BRAIN ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 209. BRICS NEUROVASCULAR CATHETERS MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 212. BRICS NEUROVASCULAR CATHETERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 213. G7 NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 214. G7 NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. G7 NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 216. G7 NEUROVASCULAR CATHETERS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. G7 NEUROVASCULAR CATHETERS MARKET SIZE, BY COATED CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 218. G7 NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 219. G7 NEUROVASCULAR CATHETERS MARKET SIZE, BY BRAIN ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 220. G7 NEUROVASCULAR CATHETERS MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
  • TABLE 221. G7 NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 222. G7 NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 223. G7 NEUROVASCULAR CATHETERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 224. NATO NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 225. NATO NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. NATO NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 227. NATO NEUROVASCULAR CATHETERS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. NATO NEUROVASCULAR CATHETERS MARKET SIZE, BY COATED CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 229. NATO NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 230. NATO NEUROVASCULAR CATHETERS MARKET SIZE, BY BRAIN ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 231. NATO NEUROVASCULAR CATHETERS MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
  • TABLE 232. NATO NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 233. NATO NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 234. NATO NEUROVASCULAR CATHETERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 235. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 236. UNITED STATES NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 237. UNITED STATES NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 239. UNITED STATES NEUROVASCULAR CATHETERS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. UNITED STATES NEUROVASCULAR CATHETERS MARKET SIZE, BY COATED CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED STATES NEUROVASCULAR CATHETERS MARKET SIZE, BY BRAIN ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED STATES NEUROVASCULAR CATHETERS MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED STATES NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 246. UNITED STATES NEUROVASCULAR CATHETERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 247. CANADA NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 248. CANADA NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. CANADA NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 250. CANADA NEUROVASCULAR CATHETERS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. CANADA NEUROVASCULAR CATHETERS MARKET SIZE, BY COATED CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 252. CANADA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 253. CANADA NEUROVASCULAR CATHETERS MARKET SIZE, BY BRAIN ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 254. CANADA NEUROVASCULAR CATHETERS MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
  • TABLE 255. CANADA NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 256. CANADA NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 257. CANADA NEUROVASCULAR CATHETERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 258. MEXICO NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 259. MEXICO NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. MEXICO NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 261. MEXICO NEUROVASCULAR CATHETERS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
  • TABLE 262. MEXICO NEUROVASCULAR CATHETERS MARKET SIZE, BY COATED CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 263. MEXICO NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 264. MEXICO NEUROVASCULAR CATHETERS MARKET SIZE, BY BRAIN ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 265. MEXICO NEUROVASCULAR CATHETERS MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
  • TABLE 266. MEXICO NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 267. MEXICO NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 268. MEXICO NEUROVASCULAR CATHETERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 269. BRAZIL NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 270. BRAZIL NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 271. BRAZIL NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 272. BRAZIL NEUROVASCULAR CATHETERS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
  • TABLE 273. BRAZIL NEUROVASCULAR CATHETERS MARKET SIZE, BY COATED CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 274. BRAZIL NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 275. BRAZIL NEUROVASCULAR CATHETERS MARKET SIZE, BY BRAIN ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 276. BRAZIL NEUROVASCULAR CATHETERS MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
  • TABLE 277. BRAZIL NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 278. BRAZIL NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 279. BRAZIL NEUROVASCULAR CATHETERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 280. UNITED KINGDOM NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 281. UNITED KINGDOM NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 282. UNITED KINGDOM NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 283. UNITED KINGDOM NEUROVASCULAR CATHETERS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
  • TABLE 284. UNITED KINGDOM NEUROVASCULAR CATHETERS MARKET SIZE, BY COATED CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 285. UNITED KINGDOM NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 286. UNITED KINGDOM NEUROVASCULAR CATHETERS MARKET SIZE, BY BRAIN ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 287. UNITED KINGDOM NEUROVASCULAR CATHETERS MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
  • TABLE 288. UNITED KINGDOM NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 289. UNITED KINGDOM NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 290. UNITED KINGDOM NEUROVASCULAR CATHETERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 291. GERMANY NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 292. GERMANY NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 293. GERMANY NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 294. GERMANY NEUROVASCULAR CATHETERS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
  • TABLE 295. GERMANY NEUROVASCULAR CATHETERS MARKET SIZE, BY COATED CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 296. GERMANY NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 297. GERMANY NEUROVASCULAR CATHETERS MARKET SIZE, BY BRAIN ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 298. GERMANY NEUROVASCULAR CATHETERS MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
  • TABLE 299. GERMANY NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 300. GERMANY NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 301. GERMANY NEUROVASCULAR CATHETERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 302. FRANCE NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 303. FRANCE NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 304. FRANCE NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 305. FRANCE NEUROVASCULAR CATHETERS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
  • TABLE 306. FRANCE NEUROVASCULAR CATHETERS MARKET SIZE, BY COATED CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 307. FRANCE NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 308. FRANCE NEUROVASCULAR CATHETERS MARKET SIZE, BY BRAIN ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 309. FRANCE NEUROVASCULAR CATHETERS MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
  • TABLE 310. FRANCE NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 311. FRANCE NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 312. FRANCE NEUROVASCULAR CATHETERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 313. RUSSIA NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 314. RUSSIA NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 315. RUSSIA NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 316. RUSSIA NEUROVASCULAR CATHETERS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
  • TABLE 317. RUSSIA NEUROVASCULAR CATHETERS MARKET SIZE, BY COATED CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 318. RUSSIA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 319. RUSSIA NEUROVASCULAR CATHETERS MARKET SIZE, BY BRAIN ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 320. RUSSIA NEUROVASCULAR CATHETERS MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
  • TABLE 321. RUSSIA NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 322. RUSSIA NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 323. RUSSIA NEUROVASCULAR CATHETERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 324. ITALY NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 325. ITALY NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 326. ITALY NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 327. ITALY NEUROVASCULAR CATHETERS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
  • TABLE 328. ITALY NEUROVASCULAR CATHETERS MARKET SIZE, BY COATED CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 329. ITALY NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 330. ITALY NEUROVASCULAR CATHETERS MARKET SIZE, BY BRAIN ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 331. ITALY NEUROVASCULAR CATHETERS MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
  • TABLE 332. ITALY NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 333. ITALY NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 334. ITALY NEUROVASCULAR CATHETERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 335. SPAIN NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 336. SPAIN NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 337. SPAIN NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 338. SPAIN NEUROVASCULAR CATHETERS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
  • TABLE 339. SPAIN NEUROVASCULAR CATHETERS MARKET SIZE, BY COATED CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 340. SPAIN NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 341. SPAIN NEUROVASCULAR CATHETERS MARKET SIZE, BY BRAIN ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 342. SPAIN NEUROVASCULAR CATHETERS MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
  • TABLE 343. SPAIN NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 344. SPAIN NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 345. SPAIN NEUROVASCULAR CATHETERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 346. CHINA NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 347. CHINA NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 348. CHINA NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 349. CHINA NEUROVASCULAR CATHETERS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
  • TABLE 350. CHINA NEUROVASCULAR CATHETERS MARKET SIZE, BY COATED CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 351. CHINA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 352. CHINA NEUROVASCULAR CATHETERS MARKET SIZE, BY BRAIN ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 353. CHINA NEUROVASCULAR CATHETERS MARKET SIZE, BY ISCHEMIC STROKE, 2018-203